Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Liver Neoplasms 1Disease 1Colorectal Neoplasms 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Mammography 4Magnetic Resonance Spectroscopy 3pembrolizumab 1Vertical Dimension 1Therapeutics 1TKM-080301 1Surveys and Questionnaires 1Sensitivity Training Groups 1Self-Management 1Referral and Consultation 1Quality of Life 1Professional Autonomy 1Patient Positioning 1Paclitaxel 1Methylene Blue 1Mass Screening 1Magnetic Resonance Imaging 1Interviews as Topic 1Interleukin-15 1Gemcitabine 1Exercise 1Drug Delivery Systems 1Doxorubicin 1Counseling 1Blood Specimen Collection 1Biopsy 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease × TKM-080301 × Breast × Clear all
NCT01437007 2018-08-03

TKM 080301 for Primary or Secondary Liver Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
1 enrolled
BreastGastrointestinalGynecologic

Adenocarcinoma, Breast Neoplasms, Disease, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡